Welcome to LookChem.com Sign In|Join Free

CAS

  • or

188576-49-0

Post Buying Request

188576-49-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

188576-49-0 Usage

Description

TERT-BUTYL 7-HYDROXY-3,4-DIHYDROISOQUINOLINE-2(1H)-CARBOXYLATE is a chemical compound that serves as a valuable reagent in the synthesis of biologically active small molecules. Its unique structure and properties make it a promising candidate for various applications in the pharmaceutical and chemical industries.

Uses

Used in Pharmaceutical Industry:
TERT-BUTYL 7-HYDROXY-3,4-DIHYDROISOQUINOLINE-2(1H)-CARBOXYLATE is used as a reagent for the preparation of biologically active small molecules. Its role in the synthesis of these molecules is crucial, as it can contribute to the development of new drugs and therapies for various medical conditions.
Used in Chemical Industry:
In the chemical industry, TERT-BUTYL 7-HYDROXY-3,4-DIHYDROISOQUINOLINE-2(1H)-CARBOXYLATE is utilized as a reagent for the synthesis of various chemical compounds. Its unique properties and reactivity make it a valuable component in the development of new materials and products with potential applications in various fields.

Check Digit Verification of cas no

The CAS Registry Mumber 188576-49-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,8,8,5,7 and 6 respectively; the second part has 2 digits, 4 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 188576-49:
(8*1)+(7*8)+(6*8)+(5*5)+(4*7)+(3*6)+(2*4)+(1*9)=200
200 % 10 = 0
So 188576-49-0 is a valid CAS Registry Number.
InChI:InChI=1/C14H19NO3/c1-14(2,3)18-13(17)15-7-6-10-4-5-12(16)8-11(10)9-15/h4-5,8,16H,6-7,9H2,1-3H3

188576-49-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name tert-butyl 7-hydroxy-3,4-dihydro-1H-isoquinoline-2-carboxylate

1.2 Other means of identification

Product number -
Other names 7-Hydroxy-3,4-dihydro-1H-isoquinoline-2-carboxylic acid tert-butyl ester

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:188576-49-0 SDS

188576-49-0Relevant articles and documents

MONOCYCLIC B-LACTAM COMPOUND FOR TREATING BACTERIAL INFECTION

-

, (2020/12/16)

Disclosed are a class of new monocyclic β-lactam compounds, an isomer thereof or pharmaceutically acceptable salts thereof, and a pharmaceutical composition comprising the compounds, and the use of same in preparing drugs for treating diseases associated

DIHYDROISOQUINOLINE-2(1H)-CARBOXAMIDE AND RELATED COMPOUNDS AND THEIR USE IN TREATING MEDICAL CONDITIONS

-

Paragraph 000571, (2019/11/04)

The invention provides dihydroisoquinoline-2(1H)-carboxamide and related compounds, pharmaceutical compositions, and their use in the treatment of medical conditions, such as cancer, and in inhibiting HPK1 activity.

Of tetracyclic Anaplastic lymphoma kinase inhibitors (by machine translation)

-

Paragraph 0280; 0281; 0282, (2016/10/08)

The invention belongs to the field of medical technology, in particular to general formula (I) as shown in of tetracyclic Anaplastic lymphoma kinase inhibitor, its pharmaceutically acceptable salt or a stereoisomer thereof, wherein R 1, R 2, R 3, R 4, R 5 and A link like defined in the specification. The invention also relates to methods of preparing such compounds, pharmaceutical preparations comprising these compounds and pharmaceutical composition, the compound and, its pharmaceutically acceptable salts or stereoisomers thereof, in the preparation of the treatment and/or prevention of Anaplastic lymphoma kinase-mediated cancer diseases related to the application of the medicament. (by machine translation)

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 188576-49-0